Carlos Honrado

Carlos Honrado serves as a Research Fellow at the International Iberian Nanotechnology Laboratory (INL) within the Medical Devices group and Diéguez Research Group. Since November 2021, he has advanced microfluidic device development for biomedical applications, notably leading the EVOLVE project as a Marie Skłodowska-Curie Actions fellow since September 2022 to isolate and analyze extracellular vesicles in endometrial cancer contexts.

His academic foundation includes:

• MSc in Biomedical Engineering from the University of Minho (2014), with thesis research conducted at the University of Southeastern Norway during an ERASMUS exchange
• PhD from the University of Southampton (2018) focused on label-free single particle analysis and separation

Honrado's research integrates microfluidics, cancer biology, and diagnostic engineering to develop point-of-care biomedical devices. His work specifically targets extracellular vesicle isolation for endometrial cancer therapeutics, leveraging label-free particle analysis techniques refined during his postdoctoral tenure at the University of Virginia (2018-2021).

His recognition includes:

• Marie Skłodowska-Curie Actions Individual Fellowship for the EVOLVE project (2022)

No student advising details are documented, though he maintains an active research profile with 19 peer-reviewed publications (13 as first author) and an h-index of 10. His intellectual property contributions include one approved patent and five filed patents.

Within INL's Diéguez Research Group, Honrado leads the Medical Devices subgroup focused on translating microfluidic innovations into clinical cancer diagnostics, supported by his Marie Curie fellowship and prior University of Virginia research experience.